Frequently Asked Questions:
The global onychomycosis treatment market moderately suffered from the COVID-19 pandemic, which resulted in a decline of over 1.6% in revenue generated in 2020.
North American region accounted for the highest share in the global onychomycosis treatment market regarding value and volume.
The increasing prevalence of onychomycosis among the general population and the introduction of water-soluble antifungal treatment solutions are driving growth in the global onychomycosis treatment market.
The distal subungual onychomycosis segment had a major share in 2021, with more than 30% of the market revenue. Besides, the white superficial onychomycosis segment is projected to witness the fastest growth.
The drug treatment segment had a major share in the global market in 2021 and is projected to continue its dominance over the forecast period.